Literature DB >> 25575413

Long-term increased factor VIII levels are associated to interleukin-6 levels but not to post-thrombotic syndrome in patients with deep venous thrombosis.

Luis Fernando Bittar1, Bruna de Moraes Mazetto2, Fernanda L Andrade Orsi2, Marina P Collela2, Erich Vinícius De Paula2, Joyce M Annichino-Bizzacchi2.   

Abstract

INTRODUCTION: Increased FVIII levels are a well established risk factor for deep venous thrombosis (DVT), whose etiopathogenesis is not yet well understood. In this study, we aimed to evaluate the possibility that inflammatory markers and post-thrombotic syndrome (PTS) could contribute to FVIII levels in patients with a history of DVT. DESIGN AND METHODS: It is a case-control study that included 68 patients with DVT of the lower limbs 32 months after the acute episode, and 67 healthy adults as controls. We evaluated plasma levels of FVIII, VWF, D-dimer and serum levels of CRP, IL-6, IL-8, TNF-α in patients and controls. The presence of PTS was evaluated by the Villalta scale.
RESULTS: Patients with DVT presented higher levels of FVIII, VWF and D-dimer when compared to controls (P ≤ 0.001). Almost 50% of patients presented FVIII levels above 90th percentile. Furthermore, IL-6 (1.19 vs. 0.98 pg/mL, P = 0.01) and TNF-α (2.27 vs. 1.57 pg/mL, P ≤ 0.001) were also higher in patients when compared to controls. In a linear regression multivariate model, VWF and IL-6 levels were independent factors associated with FVIII levels (P ≤ 0.001). FVIII levels were not increased in patients with PTS. Patients with PTS showed higher levels of IL-8 when compared to patients without PTS (23.03 vs. 18.20 pg/mL, P = 0.04).
CONCLUSIONS: In conclusion, we demonstrated that DVT is associated with increased levels of inflammatory and coagulation markers, including FVIII, even a long time after the acute episode. Moreover, IL-6 levels were an independent factor associated with FVIII levels. Finally, PTS seems to be related to inflammatory cytokine IL-8, a proinflammatory and proangiogenic chemokine, but not to FVIII levels.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Deep venous thrombosis; Factor VIII; Inflammation; Post-thrombotic syndrome; Von Willebrand factor

Mesh:

Substances:

Year:  2014        PMID: 25575413     DOI: 10.1016/j.thromres.2014.12.024

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval Project.

Authors:  Bernd Frank; Liana Ariza; Heidrun Lamparter; Vera Grossmann; Jürgen H Prochaska; Alexander Ullmann; Florentina Kindler; Gerhard Weisser; Ulrich Walter; Karl J Lackner; Christine Espinola-Klein; Thomas Münzel; Stavros V Konstantinides; Philipp S Wild
Journal:  BMJ Open       Date:  2015-07-01       Impact factor: 2.692

2.  Meta-analysis of the role of IL-6 rs1800795 polymorphism in the susceptibility to prostate cancer: Evidence based on 17 studies.

Authors:  Tong-Zu Liu; Zhong-Qiang Guo; Ting Wang; Yue Cao; Di Huang; Xing-Huan Wang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

Review 3.  Cytokines, Adhesion Molecules, and Matrix Metalloproteases as Predisposing, Diagnostic, and Prognostic Factors in Venous Thrombosis.

Authors:  Knut A Mosevoll; Silje Johansen; Øystein Wendelbo; Ina Nepstad; Øystein Bruserud; Håkon Reikvam
Journal:  Front Med (Lausanne)       Date:  2018-05-22

4.  Duration of labor among women with thromboembolic events: A Swedish register study.

Authors:  Susanne Hesselman; Anna Wikman; Roxanne Hastie; Anna-Karin Wikström; Lina Bergman; Anna Sandström
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2021-07-22

Review 5.  Role of neutrophils, platelets, and extracellular vesicles and their interactions in COVID-19-associated thrombopathy.

Authors:  Antoine Caillon; Antonin Trimaille; Julie Favre; Laurence Jesel; Olivier Morel; Gilles Kauffenstein
Journal:  J Thromb Haemost       Date:  2021-11-09       Impact factor: 16.036

6.  Increased inflammation and endothelial markers in patients with late severe post-thrombotic syndrome.

Authors:  Luis Fernando Bittar; Letícia Queiroz da Silva; Fernanda Loureiro de Andrade Orsi; Kiara Cristina Senger Zapponi; Bruna de Moraes Mazetto; Erich Vinícius de Paula; Silmara Aparecida de Lima Montalvão; Joyce Maria Annichino-Bizzacchi
Journal:  PLoS One       Date:  2020-01-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.